• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过 NMR 数据研究不同他汀类药物与模型膜的相互作用。

Interaction of different statins with model membranes by NMR data.

机构信息

Kazan (Volga Region) Federal University, 18 Kremlevskaya St., 420008 Kazan, Russian Federation.

Kazan (Volga Region) Federal University, 18 Kremlevskaya St., 420008 Kazan, Russian Federation.

出版信息

Biochim Biophys Acta Biomembr. 2017 Mar;1859(3):295-300. doi: 10.1016/j.bbamem.2016.12.006. Epub 2016 Dec 16.

DOI:10.1016/j.bbamem.2016.12.006
PMID:27989745
Abstract

Hydroxy-methyl-glutaryl-coenzyme A (HMG-CoA) reductase inhibitors or statins reduce the amount of low-density lipoprotein (LDL) cholesterol, which is known as a well-established risk factor for atherosclerosis. Despite the fact that statins have a common pharmacologic target essential to sterol biosynthesis, their efficacy, safety, and potential non-LDL actions vary significantly for different statins. There is a hypothesis that pharmacological features of statins depend on their location in cell membrane, but to the present day there is a lack of information in literature on interactions of statins with the surface of the cell membrane in liquid media. The results of NMR experiments showed that all studied statins form intermolecular complexes with models of cell membranes (dodecylphosphocholine micelles) in water solution. Locations of pravastatin, simvastatin, fluvastatin and cerivastatin on model membranes were established by NOESY NMR data. Distinctions in their positions can explain differences in pharmacological properties of studied compounds.

摘要

羟甲基戊二酰辅酶 A(HMG-CoA)还原酶抑制剂或他汀类药物可降低低密度脂蛋白(LDL)胆固醇的含量,已知 LDL 胆固醇是动脉粥样硬化的一个既定危险因素。尽管他汀类药物具有共同的、对固醇生物合成至关重要的药理学靶点,但不同的他汀类药物在疗效、安全性和潜在的非 LDL 作用方面存在显著差异。有一种假设认为,他汀类药物的药理学特征取决于它们在细胞膜中的位置,但迄今为止,关于他汀类药物与液体介质中细胞膜表面相互作用的文献信息仍然缺乏。NMR 实验结果表明,所有研究的他汀类药物在水溶液中均与细胞膜模型(十二烷基磷酸胆碱胶束)形成分子间复合物。通过 NOESY NMR 数据确定了普伐他汀、辛伐他汀、氟伐他汀和西立伐他汀在模型膜上的位置。它们位置的差异可以解释研究化合物药理学特性的差异。

相似文献

1
Interaction of different statins with model membranes by NMR data.通过 NMR 数据研究不同他汀类药物与模型膜的相互作用。
Biochim Biophys Acta Biomembr. 2017 Mar;1859(3):295-300. doi: 10.1016/j.bbamem.2016.12.006. Epub 2016 Dec 16.
2
Interaction of statins with phospholipid bilayers studied by solid-state NMR spectroscopy.通过固态 NMR 光谱研究他汀类药物与磷脂双层的相互作用。
Biochim Biophys Acta Biomembr. 2019 Mar 1;1861(3):584-593. doi: 10.1016/j.bbamem.2018.12.013. Epub 2018 Dec 20.
3
Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences.HMG-CoA还原酶抑制剂的药效学与药代动力学。异同点。
Clin Pharmacokinet. 1997 May;32(5):403-25. doi: 10.2165/00003088-199732050-00005.
4
Nitric oxide (NO)-releasing statin derivatives, a class of drugs showing enhanced antiproliferative and antiinflammatory properties.释放一氧化氮(NO)的他汀类衍生物,这是一类具有增强的抗增殖和抗炎特性的药物。
Proc Natl Acad Sci U S A. 2004 Jun 1;101(22):8497-502. doi: 10.1073/pnas.0401996101.
5
Binding thermodynamics of statins to HMG-CoA reductase.他汀类药物与HMG-CoA还原酶的结合热力学
Biochemistry. 2005 Sep 6;44(35):11741-8. doi: 10.1021/bi050905v.
6
Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.在常规临床实践中,与其他他汀类药物相比,瑞舒伐他汀治疗的老年患者的低密度脂蛋白胆固醇(LDL-C)水平及LDL-C达标情况。
Am J Geriatr Pharmacother. 2007 Sep;5(3):185-94. doi: 10.1016/j.amjopharm.2007.10.002.
7
A literature search on pharmacokinetic drug interactions of statins and analysis of how such interactions are reflected in package inserts in Japan.一项关于他汀类药物药代动力学药物相互作用的文献检索以及此类相互作用在日本药品说明书中的体现分析。
J Clin Pharm Ther. 2005 Feb;30(1):21-37. doi: 10.1111/j.1365-2710.2004.00605.x.
8
An economic analysis of the Atorvastatin Comparative Cholesterol Efficacy and Safety Study (ACCESS).阿托伐他汀比较胆固醇疗效与安全性研究(ACCESS)的经济分析。
Pharmacoeconomics. 2003;21 Suppl 1:13-23. doi: 10.2165/00019053-200321001-00002.
9
A cost-effectiveness model of alternative statins to achieve target LDL-cholesterol levels.一种用于实现低密度脂蛋白胆固醇目标水平的替代他汀类药物的成本效益模型。
Int J Clin Pract. 2001 May;55(4):243-9.
10
Characterization of interactions of simvastatin, pravastatin, fluvastatin, and pitavastatin with bovine serum albumin: multiple spectroscopic and molecular docking.辛伐他汀、普伐他汀、氟伐他汀和匹伐他汀与牛血清白蛋白相互作用的表征:多种光谱法和分子对接法
J Biomol Struct Dyn. 2017 May;35(7):1529-1546. doi: 10.1080/07391102.2016.1188416. Epub 2016 Aug 3.

引用本文的文献

1
HSQC-NMR spectroscopy and exploratory data analysis of crude oil residue in relation to the time of spill.与泄漏时间相关的原油残渣的HSQC核磁共振光谱法及探索性数据分析。
RSC Adv. 2025 Jun 4;15(24):18910-18919. doi: 10.1039/d5ra00826c.
2
Molecules in the Serotonin-Melatonin Synthesis Pathway Have Distinct Interactions with Lipid Membranes.血清素 - 褪黑素合成途径中的分子与脂质膜具有不同的相互作用。
J Phys Chem B. 2025 Mar 13;129(10):2687-2700. doi: 10.1021/acs.jpcb.4c08750. Epub 2025 Feb 27.
3
Influence of Simvastatin and Pravastatin on the Biophysical Properties of Model Lipid Bilayers and Plasma Membranes of Live Cells.
辛伐他汀和普伐他汀对模型脂质双层和活细胞质膜生物物理性质的影响。
ACS Biomater Sci Eng. 2024 Sep 9;10(9):5714-5722. doi: 10.1021/acsbiomaterials.4c00911. Epub 2024 Aug 24.
4
Statin Action Targets Lipid Rafts of Cell Membranes: GIXD/PM-IRRAS Investigation of Langmuir Monolayers.他汀类药物作用的靶点是细胞膜脂筏:Langmuir 单分子膜的 GIXD/PM-IRRAS 研究。
J Phys Chem B. 2023 Aug 17;127(32):7135-7147. doi: 10.1021/acs.jpcb.3c02574. Epub 2023 Aug 8.
5
Smith-Lemli-Opitz syndrome: A pathophysiological manifestation of the Bloch hypothesis.史密斯-勒米-奥皮茨综合征:布洛赫假说的一种病理生理表现。
Front Mol Biosci. 2023 Jan 12;10:1120373. doi: 10.3389/fmolb.2023.1120373. eCollection 2023.
6
Effects of Statin Combinations on Zika Virus Infection in Vero Cells.他汀类药物组合对非洲绿猴肾细胞寨卡病毒感染的影响
Pharmaceutics. 2022 Dec 23;15(1):50. doi: 10.3390/pharmaceutics15010050.
7
Model Lipid Raft Membranes for Embedding Integral Membrane Proteins: Reconstitution of HMG-CoA Reductase and Its Inhibition by Statins.用于嵌入整合膜蛋白的模型脂筏膜:HMG-CoA 还原酶的重建及其被他汀类药物抑制。
Langmuir. 2022 Nov 15;38(45):13888-13897. doi: 10.1021/acs.langmuir.2c02115. Epub 2022 Nov 6.
8
Interaction of the pitavastatin with model membranes.匹伐他汀与模型膜的相互作用。
Biochem Biophys Rep. 2021 Sep 29;28:101143. doi: 10.1016/j.bbrep.2021.101143. eCollection 2021 Dec.
9
The Role of Structure and Biophysical Properties in the Pleiotropic Effects of Statins.他汀类药物多效性的结构和生物物理特性作用。
Int J Mol Sci. 2020 Nov 19;21(22):8745. doi: 10.3390/ijms21228745.
10
New Insights Into Targeting Membrane Lipids for Cancer Therapy.靶向膜脂用于癌症治疗的新见解
Front Cell Dev Biol. 2020 Sep 2;8:571237. doi: 10.3389/fcell.2020.571237. eCollection 2020.